Paper Details

  1. Home
  2. Paper Details

Intravenous acyclovir in genital herpes. An interim report.

Author: AdlerM W, FiddianA P, MindelA, SutherlandS

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A study of 25 patients with primary genital herpes compared intravenous acyclovir to placebo. The acyclovir group showed a significant reduction in the median time to healing of all lesions (11 days to 7 days), the median duration of viral shedding (8 days to 2 days), and the time to cessation of new lesions (2 days to 0 days). These findings indicate that intravenous acyclovir effectively reduces the severity and duration of primary genital herpes.
Paper Details　
Original Abstract of the Article :
Twenty-five patients with primary genital herpes were treated in a double-blind placebo-controlled randomized trial of intravenous acyclovir. Thirteen patients received the drug and 12 a placebo. Three in each group were male. In the acyclovir group 10 patients had true primary herpes compared with ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0002-9343(82)90121-8

データ提供：米国国立医学図書館（NLM）

Acyclovir: A Weapon Against Genital Herpes

Genital herpes, a viral infection that affects millions worldwide, can be a challenging and often painful condition. Imagine a vast desert, where the threat of herpes lingers, causing discomfort and impacting daily life. This research explores the effectiveness of intravenous acyclovir in treating primary genital herpes, offering a potential oasis of relief for those affected by this condition.

A Ray of Hope: Intravenous Acyclovir's Impact on Genital Herpes

The study, a double-blind placebo-controlled trial involving 25 patients, found that intravenous acyclovir significantly reduced the duration and severity of primary genital herpes, accelerating healing and decreasing viral shedding. It's like a refreshing spring in the desert, offering a respite from the discomfort and challenges of the condition. The findings highlight the potential of intravenous acyclovir as a valuable treatment option for primary genital herpes.

Seeking a Cure: The Ongoing Search for Effective Treatment Options

The study, while promising, reinforces the need for further research to develop even more effective treatments for genital herpes. It's like a desert expedition, where researchers continue to seek new pathways to cure this persistent condition. The study's findings provide valuable insights into the potential of acyclovir, paving the way for future research and development of new and improved treatment strategies.

Dr. Camel's Conclusion

Intravenous acyclovir offers a beacon of hope for individuals suffering from primary genital herpes, providing a potential oasis of relief in a challenging desert. This research, while not a complete cure, underscores the importance of continuous exploration and innovation in the fight against this persistent viral infection.

Date :
  1. Date Completed 1982-09-10
  2. Date Revised 2019-06-27
Further Info :

Pubmed ID

7048923

DOI: Digital Object Identifier

10.1016/0002-9343(82)90121-8

Related Literature

Article Analysis
・Effective treatment of genital herpes
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.